Researchers from Miguel Hernández University of Elche (UMH) in Spain have identified an effective strategy to reduce structural liver damage and improve hepatic vascular function in cirrhosis.

The intestine was removed and linearized in ice-cold normal saline solution. Duodenum, jejunum, ileum, and colon were embedded in OCT, sectioned, and stained with hematoxylin and eosin (H&E). A score ...

In a recent study published in the IUBMB journal, researchers assessed the association between platelet-activating factor (PAF) and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike ...

Explore the latest findings in liver cirrhosis treatment to reduce liver damage and improve vascular function with new ...

In four independent experiments, two serial doses of BN 50730, either 2.5 mg/kg per dose (n = 13) or 25 mg/kg per dose (n = 12), or vehicle (5% gum arabic in water;n = 21) were administered by midline ...

Our main objective was to understand the role of platelet-activating factor (PAF) and its receptor (PAF-R) in liver cirrhosis ...

As we age, our immune system quietly loses its edge, and scientists have uncovered a surprising reason why. A protein called ...

A single blood protein can make aging stem cells act young again. As people age and notice changes like graying hair or reduced muscle strength, their immune system also undergoes shifts. One key ...

Researchers from Miguel Hernández University of Elche (UMH) in Spain have identified an effective strategy to reduce structural liver damage and ...

This article is part of a series on recent advances in the science and medicine of longevity. What do blood transfusions, exercise, and a longevity hormone have in common? All three help improve ...

More than half of patients in a Phase III clinical trial who received a limited course of the experimental monoclonal antibody ianalumab for primary immune thrombocytopenia (ITP), an autoimmune ...